Drug-drug interaction pattern recognition

Drugs in R and D

Volumn 10, Issue 1, 2010, Pages 9-24

  Duan, John Z ^a,b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b CDER   (United States)

Author keywords

Clinical pharmacokinetics; Drug interactions

Indexed keywords

AREA UNDER THE CURVE; ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG INTERACTION; HUMAN; MAXIMUM PLASMA CONCENTRATION; PRIORITY JOURNAL; SIMULATION; TIME TO MAXIMUM PLASMA CONCENTRATION;

COMPUTER SIMULATION; DRUG INTERACTIONS; HUMANS; MODELS, STATISTICAL; PATTERN RECOGNITION, AUTOMATED; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS;

EID: 79953183033     PISSN: 11745886     EISSN: 11796901     Source Type: Journal    
DOI: 10.2165/11537440-000000000-00000     Document Type: Article

References (25)

1. Gibaldi N, Perrier D. Pharmacokinetics. 2nd ed. New York (NY): Plenum Publishing Corp, 1982
2. Rakhit A, Pantze MP, Fettner S, et al. The effects of CYP3A4 inhibition on erlotinib pharmacokinetics: computerbased simulation (SimCYP) predicts in vivo metabolic inhibition. Eur J Clin Pharmacol 2008;64:31-41
3. Laine K, Anttila M, Helminen A, et al. Dose linearity study of selegiline pharmacokinetics after oral administration: evidence for strong drug interaction with female sex steroids. Br J Clin Pharmacol 1999;47:249-54 (Pubitemid 29131337)
4. Guns ES, Denyssevych T, Dixon R, et al. Drug interaction studies between paclitaxel (Taxol) and OC144-093: a new modulator of MDR in cancer chemotherapy. Eur J Drug Metab Pharmacokinet 2002;27:119-26 (Pubitemid 34594896)
5. ® (imatinib mesylate) tablets (Novartis). Greenwood Village (CO): Thomson Micromedex, 2009
6. Schneck DW, Birmingham BK, Zalikowski JA, et al. The effect of gemfibrozil on the pharmacokinetics of rosuvastatin. Clin Pharmacol Ther 2004;75:455-63 (Pubitemid 38534566)
7. Kiser JJ, Gerber JG, Predhomme JA, et al. Drug/Drug interaction between lopinavir/ritonavir and rosuvastatin in healthy volunteers. J Acquir Immune Defic Syndr 2008;47:570-8 (Pubitemid 351442013)
8. Simonson SG, Raza A, Martin PD, et al. Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine. Clin Pharmacol Ther 2004;76:167-77 (Pubitemid 39013406)
9. Kovarik JM, Kalbag J, Figueiredo J, et al. Differential influence of two cyclosporine formulations on everolimus pharmacokinetics: a clinically relevant pharmacokinetic interaction. J Clin Pharmacol 2002;42:95-9 (Pubitemid 34038374)
10. Yasui-Furukori N, Saito M, Inoue Y, et al. Terbinafine increases the plasma concentration of paroxetine after a single oral administration of paroxetine in healthy subjects. Eur J Clin Pharmacol 2007;63:51-6 (Pubitemid 46025473)
11. ® (terbinafine hydrochloride) oral granules (Novartis). Greenwood Village (CO): Thomson Micromedex, 2009
12. ® (duloxetine hydrochloride) delayed release capsules (Lilly). Greenwood Village (CO): Thomson Micromedex, 2009
13. Moody DE, Walsh SL, Rollins DE, et al. Ketoconazole, a cytochrome P450 3A4 inhibitor, markedly increases concentrations of levo-acetyl-alpha-methadol in opioid-naive individuals. Clin Pharmacol Ther 2004;76:154-66 (Pubitemid 39013405)
14. ® (atomoxetine hydrochloride) capsules for oral use (Lilly). Greenwood Village (CO): Thomson Micromedex, 2009
15. Tornio A, Niemi M, Neuvonen M, et al. The effect of gemfibrozil on repaglinide pharmacokinetics persists for at least 12 h after the dose: evidence formechanism-based inhibition of CYP2C8 in vivo. Clin Pharmacol Ther 2008;84:403-11
16. Moton A, Ma L, Krishna G, et al. Effects of oral posaconazole on the pharmacokinetics of sirolimus. Curr Med Res Opin 2009;25:701-7
17. Hsu A, Granneman GR, Cao G, et al. Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir. Clin Pharmacol Ther 1998;63:453-64 (Pubitemid 28214969)
18. ® (fluticasone propionate, salmeterol xinafoate) 100/50 (GlaxoSmithKline). Greenwood Village (CO): Thomson Micromedex, 2009
19. Wendrow A. Drug Combinations quick reference guide. 6-1-2000 [online]. Available from URL: http://www.thefreelibrary.com/-/print/PrintArticle.aspx?id= 65014034 [Accessed 2010 Apr. 30]
20. Ebert U, Oertel R, Kirch W. Influence of grapefruit juice on scopolamine pharmacokinetics and pharmacodynamics in healthy male and female subjects. Int J Clin Pharmacol Ther 2000;38:523-31
21. Food and Drug Administration. Guidance for industry drug interaction studies: study design, data analysis, and implications for dosing and labeling. Silver Spring (MD): FDA, 2006
22. Tozer TN. Concepts basic to pharmacokinetics. Pharmacol Ther 1981;12:109-31 (Pubitemid 11183303)
23. Schapiro JM, Winters MA, Stewart F, et al. The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients. Ann Intern Med 1996;124:1039-50
24. Watkins PB, Wrighton SA, Schuetz EG, et al. Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man. J Clin Invest 1987;80:1029-36 (Pubitemid 18075638)
25. Kolars JC, Lown KS, Schmiedlin-Ren P, et al. CYP3A gene expression in human gut epithelium. Pharmacogenetics 1994;4:247-59 (Pubitemid 24337433)